After COVID relief negotiations between White House representatives and Democratic congressional leaders reached an impasse, President Trump signed a series of Executive Orders on August 8, 2020, the White House argued would restore lapsed benefits and address some of the pandemic’s economic impacts.

AIBS has announced a new webinar, Building Resilient Scientific Societies: Open Discussion on Member Engagement in the COVID Era, which will take place August 27, 2020 at 1:00pm ET.

On July 27, 2020, Republican lawmakers in the Senate unveiled a $1 trillion stimulus package to address the impacts of the ongoing coronavirus pandemic.

On behalf of the scientific, medical, and patient communities dedicated to advancing human health, we write to express our collective, strong support for the continued use of human fetal tissue in life-saving biomedical research.

The biological sciences research and education community is deeply concerned by the July 6, 2020, guidance from United States Immigration and Customs Enforcement (ICE) that would force international students to leave the country if they do not participate in in-person instruction during the fall 2020 semester.

On June 24, 2020, lawmakers in the U.S. House of Representatives introduced bipartisan legislation to provide emergency relief appropriations for federal science agencies to support the research community during the ongoing public health crisis.

AIBS has announced a new webinar, Building Resilient Scientific Societies - Scientific Conferences in the COVID-19 Era, which will take place Tuesday July 21, 2020 at 1:00pm ET.

AIBS has been awarded a Standard Grant from the National Science Foundation on the science of peer review entitled: “Reliability, Risk Aversion, and Bias in Grant Peer Review”.

AIBS will be having a special meeting of the AIBS Council on June 30, 2020 at 2:00 PM Eastern. This webinar discussion will explore opportunities for scientific societies to combat racism and intolerance.

During the COVID-19 crisis, AIBS has continued to support our clients, partners, and members in our collective efforts to promote informed decision-making that advances science for the benefit of society. We continue to work to help the biological sciences community respond the effects of disruptions arising from COVID-19, and to prepare for continued impact and effectiveness as we all prepare for new models of operation.